NCT06913088
Ultrasonication-mediated Microbubbles Dressing for Hand Arthritis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 4 words Show 4 more changesShow less
- Trial completed
- Final enrollment: 52 participants (planned 60)
- Primary completion date changed from estimate of Jul 1, 2025 to Sep 30, 2025
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Apr 1, 2025 to Apr 2, 2025
- Notable Eligibility criteria shortened, about 6 words
- Primary endpoints revised (3)
- Secondary endpoints: details revised at 1 of 1 entry
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Clinical response
Timeframe: day 8
B-mode response
Timeframe: day 8
Conventional power Doppler (PD) response
Timeframe: day 8
Secondary (1)
Ultrafast PD response
Arms and interventions
MBUS groupExperimental
ultrasonication-mediated microbubbles dressing (day 1,3,5) + piroxicam gel (day 2,4,6,7)
US groupSham comparator
ultrasonication using pure gel (day 1,3,5) + piroxicam gel (day 2,4,6,7)
Control groupNo intervention
piroxicam gel alone (day 1-7)
Procedures: ultrasonication-mediated microbubbles dressing, ultrasonication using pure gel
Sites
1 site in 1 country
- Taichung Veterans General HospitalTaichung, Taichung, Taiwan